- Filed
- Feb 10, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 31, 2025 | 45.24M sh |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $30.59M |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $36.88M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $90.62M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $93.46M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $38.55M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $42.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $195.04M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $198.95M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $176.84M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $185.05M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $395.96M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $413.75M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 46.29M sh |
| Stock Repurchased | Q1 2025 · Dec 31, 2023 | $0 |
| Capex | Q1 2025 · Dec 31, 2023 | $241K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | −$9.46M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $213.8M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $205.19M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | −$0.13 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | −$0.13 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $15.54M |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $8.87M |
| Net Income | Q1 2025 · Dec 31, 2023 | −$5.79M |
| Operating Income | Q1 2025 · Dec 31, 2023 | −$6.92M |
| Revenue | Q1 2025 · Dec 31, 2023 | $36.92M |